Thu, Mar 5, 2015, 11:21 AM EST - U.S. Markets close in 4 hrs 39 mins


% | $
Quotes you view appear here for quick access.

Myrexis, Inc. Message Board

  • brilliantpost4u brilliantpost4u Oct 1, 2011 12:16 AM Flag

    A new high priced CFO?

    This better be a prelude to liquidating the company, or I am going to be even MORE angry. Why the heck do we need a new fat paycheck when the company is making nothing, no plans to make anything, and living off daddy's bankroll (spinoff cash). I guess I will never invest in a Utah company again.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Leave already, neither of us knows what the future will bring for Myrexis.

      • 2 Replies to twelvetooth
      • Why don't you leave already twelvetooth? What is the most intelligent thing you have ever posted? "Azixa is not dead"? (the CEO says it is). "Hobden is brilliant"? (he is a total business moron who drove this company into the tank).
        "Something is afoot" (fascinating post) You have been part of the problem, not the solution. Why don't you take a long hike in Moab and mysteriously get lost.

      • I listened to the latest presentation (Q&A not webccast). It sure sounded like the new business plan is to license the entire pipeline and get out of the research business. That would make the CFO a key player.

        I'd be pitching Azixa mostly to Roche; a combination with Avastin looks extremely attractive in principle (but very expensive to develop). Of the active programs, I'd be pushing hardest to license the metabolism inhibitor: the other two have the potential to become a lot more valuable than they presently are with a little more research.

        This train wreck makes me appreciate Incyte a lot more. Their stock is way off, but starting from the same sort of discovery program, and with a lot less seed money, they're getting two drugs to market [almost] for sure. The key seems to be that their technical leader is almost as good a money guy as the real money guys.

0.140.0000(0.00%)10:40 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.